Trial Profile
Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Adrenomedullin (Primary)
- Indications Pulmonary hypertension
- Focus Adverse reactions; Diagnostic use; Proof of concept
- 26 Apr 2016 New trial record